Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTrinity Biotech Plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2026 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q3 2026 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
Trinity Biotech Plc Earnings Date And Information
Trinity Biotech Plc last posted its earnings results on Tuesday, December 23rd, 2025. The company reported $-0.32 earnings per share for the quarter, topping analysts' consensus estimates of $-0.51 by $0.19. The company had revenue of 14.25 M for the quarter and had revenue of 61.56 M for the year. Trinity Biotech Plc has generated $-2 earnings per share over the last year ($-1.77 diluted earnings per share) and currently has a price-to-earnings ratio of -0.31. Trinity Biotech Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Trinity Biotech Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/23/2025 | Q3 2025 | N/A | -$0.27 | N/A | $14.50 M | $14.25 M |
| 12/23/2025 | Q2 2025 | -$0.51 | -$0.32 | 0.19 | $10.50 M | $10.97 M |
| 05/15/2025 | Q1 2025 | -$0.30 | -$0.48 | -0.18 | N/A | $7.58 M |
| 02/28/2025 | Q4 2024 | N/A | -$1.20 | N/A | N/A | $15.86 M |
| 11/15/2024 | Q3 2024 | -$0.54 | -$0.46 | 0.08 | $16.50 M | $15.15 M |
| 10/02/2024 | Q2 2024 | N/A | -$0.71 | N/A | $15.00 M | $15.84 M |
| 04/05/2024 | Q1 2024 | N/A | -$0.37 | N/A | N/A | $14.70 M |
| 04/30/2024 | Q4 2023 | N/A | -$0.72 | N/A | N/A | $13.43 M |
| 10/06/2023 | Q3 2023 | N/A | -$0.88 | N/A | N/A | $14.68 M |
| 07/10/2023 | Q2 2023 | N/A | -$0.78 | N/A | N/A | $13.90 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.83 | N/A | N/A | $14.83 M |
| 12/31/2022 | Q4 2022 | N/A | -$1.32 | N/A | N/A | $18.04 M |
| 09/06/2023 | Q3 2022 | N/A | -$1.17 | N/A | N/A | $19.50 M |
| 06/30/2022 | Q2 2022 | -$0.20 | -$3.40 | -3.2 | N/A | $18.46 M |
| 04/11/2022 | Q1 2022 | $0.07 | -$0.33 | -0.4 | N/A | $18.78 M |
| 12/31/2021 | Q4 2021 | N/A | $0.40 | N/A | N/A | $19.53 M |
| 12/16/2021 | Q3 2021 | N/A | $0.06 | N/A | N/A | $22.00 M |
| 06/30/2021 | Q2 2021 | N/A | -$0.19 | N/A | N/A | $25.84 M |
| 05/27/2021 | Q1 2021 | N/A | $0.08 | N/A | N/A | $25.59 M |
| 04/30/2021 | Q4 2020 | N/A | -$2.40 | N/A | N/A | $32.77 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Trinity Biotech Plc Earnings: FAQ's
In the previous quarter, Trinity Biotech Plc (:TRIB) reported $-0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.51 by $0.19.
The conference call for Trinity Biotech Plc's latest earnings report can be listened to online.
The conference call transcript for Trinity Biotech Plc's latest earnings report can be read online.
Trinity Biotech Plc (:TRIB) has a recorded annual revenue of $61.56 M.
Trinity Biotech Plc (:TRIB) has a recorded net income of $-31,789,000.Trinity Biotech Plc has generated $-1.77 earnings per share over the last four quarters.
Trinity Biotech Plc (:TRIB) has a price-to-earnings ratio of -0.31 and price/earnings-to-growth ratio is 0.03.